These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36860098)

  • 41. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
    Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA
    J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 43. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
    Leduc L; Dubois E; Takser L; Rey E; David M
    J Obstet Gynaecol Can; 2007 Oct; 29(10):787-93. PubMed ID: 17915061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preconception venous thromboembolism and placenta-mediated pregnancy complications.
    Hansen AT; Schmidt M; Horváth-Puhó E; Pedersen L; Rothman KJ; Hvas AM; Sørensen HT
    J Thromb Haemost; 2015 Sep; 13(9):1635-41. PubMed ID: 26178661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inherited thrombophilia and poor pregnancy outcome.
    Brenner B; Kupferminc MJ
    Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):427-39. PubMed ID: 12787536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
    Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
    Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race.
    Tolcher MC; Sangi-Haghpeykar H; Mendez-Figueroa H; Aagaard KM
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100184. PubMed ID: 33345910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.
    Aracic N; Roje D; Jakus IA; Bakotin M; Stefanovic V
    Yonsei Med J; 2016 Sep; 57(5):1230-5. PubMed ID: 27401656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticoagulant prophylaxis for placenta mediated pregnancy complications.
    Rodger MA
    Thromb Res; 2011 Feb; 127 Suppl 3():S76-80. PubMed ID: 21262448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiplatelet agents for preventing pre-eclampsia and its complications.
    Duley L; Meher S; Hunter KE; Seidler AL; Askie LM
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
    Zheng XJ; Deng XL; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):323-8. PubMed ID: 24743831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S; Medley N; Williams MJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011192. PubMed ID: 31523806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Vascular placental pathology in high-risk groups: definition and synopsis].
    Foidart JM; Seak-San S; Emonts P; Schaaps JP
    Ann Med Interne (Paris); 2003; 154(5-6):332-9. PubMed ID: 15027587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.